Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Health Aff (Millwood). 2010 Jan-Feb;29(1):102-8. doi: 10.1377/hlthaff.2009.0525.

Genetic testing for Alzheimer's and long-term care insurance.

Author information

  • 1Duke University, Durham, North Carolina, USA. don.taylor@duke.edu

Abstract

A genetic marker known as apolipoprotein E provides a clear signal of a person's risk of developing Alzheimer's disease and thus that person's future need for long-term care. People who find that they have the variant of the trait that increases Alzheimer's disease risk are more likely to purchase long-term care insurance after receiving this information. If the information is widely introduced into the insurance market, coverage rates could be affected in different ways, depending on who possesses that information. Policymakers will eventually need to confront the issue of the use of this and other markers in the pricing of long-term care insurance.

PMID:
20048367
[PubMed - indexed for MEDLINE]
PMCID:
PMC2931337
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk